During the past decade, Ospedale di Rivoli conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale di Rivoli" #1 sponsor was "Azienda Sanitaria Locale 3, Torino" with 4 trials, followed by "Azienda Ospedaliera Città della Salute e della Scienza di Torino" with 2 trials sponsored, "Italian Society of Invasive Cardiology" with 2 trials sponsored, "Mario Negri Institute for Pharmacological Research" with 2 trials sponsored and "Azienda Ospedaliero Universitaria Maggiore della Carita" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale di Rivoli" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Eustrategy" with 1 trials as a collaborator, "Heart Care Foundation" with 1 trials as a collaborator and "Politecnico di Torino" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale di Rivoli" are "Acute Coronary Syndrome" (4 trials), "Coronary Artery Disease" (4 trials), "Atrial Fibrillation" (3 trials), "Pericarditis" (3 trials) and "Recurrence" (2 trials). Many other conditions were trialed in "Ospedale di Rivoli" in a lesser frequency.

Most popular intervention types in "Ospedale di Rivoli" are "Drug" (10 trials), "Device" (5 trials), "Other" (3 trials), "Diagnostic Test" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Abluminus DES+ Sirolimus Eluting Stent System (SES)" (1 trials), "Angio" (1 trials), "Application of Padua and IMPROVE Bleeding scores" (1 trials) and "Aspirin 100 mg OD plus clopidogrel 75 mg OD" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale di Rivoli" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale di Rivoli". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ospedale di Rivoli, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale di Rivoli, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".